Compare Cadila Healthcare with Sterling Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs STERLING BIOTECH - Comparison Results

CADILA HEALTHCARE     Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

STERLING BIOTECH 
   Change

Sterling Biotech primarily produces and distributes pharmaceutical grade gelatine globally. The company currently has a 7.5% share of the global market for pharmaceutical and nutraceutical gelatines. It has more than 70% market share in India. Sterli... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE STERLING BIOTECH CADILA HEALTHCARE/
STERLING BIOTECH
 
P/E (TTM) x 29.4 -0.4 - View Chart
P/BV x 3.5 0.0 24,643.3% View Chart
Dividend Yield % 1.0 0.0 -  

Financials

 CADILA HEALTHCARE   STERLING BIOTECH
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-19
STERLING BIOTECH
Dec-13
CADILA HEALTHCARE/
STERLING BIOTECH
5-Yr Chart
Click to enlarge
High Rs43211 4,118.1%   
Low Rs3063 9,011.8%   
Sales per share (Unadj.) Rs128.626.8 479.7%  
Earnings per share (Unadj.) Rs18.5-15.0 -124.0%  
Cash flow per share (Unadj.) Rs24.4-5.5 -446.6%  
Dividends per share (Unadj.) Rs3.500-  
Dividend yield (eoy) %0.90-  
Book value per share (Unadj.) Rs101.554.9 184.9%  
Shares outstanding (eoy) m1,023.74267.87 382.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.90.3 1,107.9%   
Avg P/E ratio x19.9-0.5 -4,286.3%  
P/CF ratio (eoy) x15.1-1.3 -1,190.3%  
Price / Book Value ratio x3.60.1 2,875.2%  
Dividend payout %18.90-   
Avg Mkt Cap Rs m378,1701,862 20,313.2%   
No. of employees `00012.41.4 918.6%   
Total wages/salary Rs m21,241547 3,884.6%   
Avg. sales/employee Rs Th10,585.05,303.3 199.6%   
Avg. wages/employee Rs Th1,707.8403.8 422.9%   
Avg. net profit/employee Rs Th1,526.5-2,959.0 -51.6%   
INCOME DATA
Net Sales Rs m131,6567,181 1,833.5%  
Other income Rs m2,01143 4,720.7%   
Total revenues Rs m133,6677,223 1,850.5%   
Gross profit Rs m29,731947 3,139.8%  
Depreciation Rs m5,9862,543 235.4%   
Interest Rs m1,9354,377 44.2%   
Profit before tax Rs m23,821-5,931 -401.6%   
Minority Interest Rs m4690-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5,303-1,924 -275.6%   
Profit after tax Rs m18,987-4,007 -473.9%  
Gross profit margin %22.613.2 171.3%  
Effective tax rate %22.332.4 68.6%   
Net profit margin %14.4-55.8 -25.8%  
BALANCE SHEET DATA
Current assets Rs m84,98114,335 592.8%   
Current liabilities Rs m73,42549,809 147.4%   
Net working cap to sales %8.8-494.0 -1.8%  
Current ratio x1.20.3 402.2%  
Inventory Days Days75403 18.5%  
Debtors Days Days110171 64.2%  
Net fixed assets Rs m133,49355,432 240.8%   
Share capital Rs m1,024268 382.2%   
"Free" reserves Rs m102,83913,935 738.0%   
Net worth Rs m103,86314,701 706.5%   
Long term debt Rs m39,4979,478 416.7%   
Total assets Rs m234,83173,988 317.4%  
Interest coverage x13.3-0.4 -3,749.9%   
Debt to equity ratio x0.40.6 59.0%  
Sales to assets ratio x0.60.1 577.7%   
Return on assets %8.90.5 1,778.7%  
Return on equity %18.3-27.3 -67.1%  
Return on capital %18.3-6.4 -284.7%  
Exports to sales %025.9 0.0%   
Imports to sales %00.2 0.0%   
Exports (fob) Rs mNA1,860 0.0%   
Imports (cif) Rs mNA12 0.0%   
Fx inflow Rs m48,4041,860 2,602.6%   
Fx outflow Rs m11,59325 46,576.9%   
Net fx Rs m36,8111,835 2,006.1%   
CASH FLOW
From Operations Rs m28,8231,719 1,677.0%  
From Investments Rs m-57,387-3,148 1,822.9%  
From Financial Activity Rs m18,8461,426 1,321.6%  
Net Cashflow Rs m-7,105-3 208,970.6%  

Share Holding

Indian Promoters % 74.8 33.9 220.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 8.3 0.0 -  
FIIs % 5.9 9.9 59.6%  
ADR/GDR % 0.0 16.9 -  
Free float % 11.0 39.3 28.0%  
Shareholders   44,069 21,482 205.1%  
Pledged promoter(s) holding % 0.0 55.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES PHARMA SCIENCE  J.B.CHEMICALS  

Compare CADILA HEALTHCARE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 143 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day today, tracking weak global cues as coronavirus cases continue to surge across the world.

Related Views on News

CADILA HEALTHCARE Announces Quarterly Results (2QFY20); Net Profit Down 79.3% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, CADILA HEALTHCARE has posted a net profit of Rs 829 m (down 79.3% YoY). Sales on the other hand came in at Rs 34 bn (up 13.7% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (1QFY20); Net Profit Down 28.9% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, CADILA HEALTHCARE has posted a net profit of Rs 3 bn (down 28.9% YoY). Sales on the other hand came in at Rs 35 bn (up 20.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (4QFY19); Net Profit Down 21.0% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 21.0% YoY). Sales on the other hand came in at Rs 37 bn (up 14.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (3QFY19); Net Profit Down 3.7% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, CADILA HEALTHCARE has posted a net profit of Rs 5 bn (down 3.7% YoY). Sales on the other hand came in at Rs 36 bn (up 9.8% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

CADILA HEALTHCARE Announces Quarterly Results (2QFY19); Net Profit Down 18.6% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, CADILA HEALTHCARE has posted a net profit of Rs 4 bn (down 18.6% YoY). Sales on the other hand came in at Rs 30 bn (down 8.4% YoY). Read on for a complete analysis of CADILA HEALTHCARE's quarterly results.

More Views on News

Most Popular

How to Find the Best Stocks for Day Trading - 1(Fast Profits Daily)

Jul 2, 2020

In the first of two videos, I'll show you how to identify the best stocks for intraday trading.

Two Agri Stocks Are Likely to Outperform Even in this Market(Profit Hunter)

Jul 2, 2020

Why we have recommended two agriculture stocks for our Hidden Treasure subscribers. Read on...

A Warning for Traders: Don't Get Addicted to Hopium(Fast Profits Daily)

Jun 30, 2020

If you are a trader, you must watch out for this dangerous addiction.

Smallcaps Are in a Sweet Spot Again: Are You Buying?(Profit Hunter)

Jul 3, 2020

This is why I believe smallcaps are the place to be in the near future.

More

India's #1 Trader
Reveals His Secrets

The Secret to Increasing Your Trading Profits Today
Get this Special Report, The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Jul 10, 2020 (Close)

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 5-YR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS